Clinical trial · Observational
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy
NCT02135679CI-TRIAL-00082802completedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
CTC levels collected pre-surgery will be correlated with pathological samples.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (7)
- label
- Cohort 1
- description
- Patients with early stage NSCLC undergoing stereotactic radiotherapy
- interventionNames
- Radiation: Radiotherapy
- label
- Cohort 2
- description
- Patients with locally advanced NSCLC undergoing standard chemoradiotherapy
- interventionNames
- Radiation: Radiotherapy
- label
- Cohort 3
- description
- Patients with stage I-III NSCLC undergoing standard, fractionated radiotherapy alone
- interventionNames
- Radiation: Radiotherapy
- label
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with biopsy-proven NSCLC who are undergoing definitive radiotherapy as a part of their treatment regimen. * Age 18 or older * Signed informed consent * Patients who are incapable of providing informed consent are excluded from participating in this study.
References
Publications (1)
- DERIVEDEvanson D, Griffin M, O'Reilly SE, Johnson T, Werner T, Kothekar E, Jahangiri P, Simone CB 2nd, Swisher-McClure S, Feigenberg SJ, Revheim ME, Zou J, Alavi A. Comparative assessment of radiation therapy-induced vasculitis using [18F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1444-1450. doi: 10.1007/s00259-023-06535-3. Epub 2023 Dec 14. PMID 38095673